Henry Schein News

Leerink Partners Adjusts Henry Schein's Price Target to $77 From $82, Keeps Market Perform Rating

MT NewswiresApr 12 06:17 ET

Henry Schein Analyst Ratings

BenzingaMar 6 05:23 ET

Barrington Boosts Price Target on Henry Schein to $90 From $82, Keeps Outperform Rating

MT NewswiresFeb 28 10:12 ET

Henry Schein Stock Faces Headwinds: Sell Rating Affirmed Amidst Growth and Revenue Challenges

TipRanksFeb 28 05:49 ET

Goldman Sachs Sticks to Its Hold Rating for Henry Schein (HSIC)

TipRanksFeb 27 22:55 ET

Henry Schein Analyst Ratings

BenzingaFeb 26 07:59 ET

Stifel Nicolaus Upgrades Henry Schein (HSIC) to a Buy

TipRanksFeb 21 08:02 ET

Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH), RegenXBio (RGNX) and Henry Schein (HSIC)

TipRanksJan 22 12:40 ET

Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), Henry Schein (HSIC) and Palatin Technologies (PTN)

TipRanksDec 21, 2023 06:50 ET

Analysts Conflicted on These Healthcare Names: Halozyme (HALO), Immunovant (IMVT) and Henry Schein (HSIC)

TipRanksDec 21, 2023 06:00 ET

What 8 Analyst Ratings Have To Say About Henry Schein

BenzingaDec 12, 2023 09:00 ET

Henry Schein Analyst Ratings

BenzingaDec 12, 2023 07:42 ET

Goldman Sachs Keeps Their Hold Rating on Henry Schein (HSIC)

TipRanksDec 5, 2023 22:25 ET

Analysts Are Bullish on Top Healthcare Stocks: Henry Schein (HSIC), DocGo (DCGO)

TipRanksNov 30, 2023 08:30 ET

Henry Schein Analyst Ratings

BenzingaNov 27, 2023 13:33 ET

Analysts Offer Insights on Healthcare Companies: Agilent (A), Henry Schein (HSIC) and Biogen (BIIB)

TipRanksNov 21, 2023 07:50 ET

What 5 Analyst Ratings Have To Say About Henry Schein

BenzingaNov 14, 2023 12:00 ET

Barrington Cuts Price Target on Henry Schein to $82 From $90, Maintains Outperform Rating

MT NewswiresNov 14, 2023 09:27 ET

Henry Schein Analyst Ratings

BenzingaNov 14, 2023 09:23 ET

Piper Sandler Keeps Their Buy Rating on Henry Schein (HSIC)

TipRanksNov 14, 2023 07:35 ET